Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Bioanalysis. 2011 Jul;3(13):1471-8. doi: 10.4155/bio.11.133.

Automated reporting of pharmacokinetic study results: gaining efficiency downstream from the laboratory.

Author information

  • Pharsight - A Certara Company, USA. pschaefer@pharsight.com

Abstract

The purpose of bioanalysis in the pharmaceutical industry is to provide 'raw' data about the concentration of a drug candidate and its metabolites as input for studies of drug properties such as pharmacokinetic (PK), toxicokinetic, bioavailability/bioequivalence and other studies. Building a seamless workflow from the laboratory to final reports is an ongoing challenge for IT groups and users alike. In such a workflow, PK automation can provide companies with the means to vastly increase the productivity of their scientific staff while improving the quality and consistency of their reports on PK analyses. This report presents the concept and benefits of PK automation and discuss which features of an automated reporting workflow should be translated into software requirements that pharmaceutical companies can use to select or build an efficient and effective PK automation solution that best meets their needs.

PMID:
21728771
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Atypon
    Loading ...
    Write to the Help Desk